Introduction:
Urological cancers involve cancers of the kidney, bladder, ureter, urethra, penile, and prostate. Precision medicine has been introduced with technological advancements and an understanding of how cancer works. Based on each patient’s specific cancer profile and studying their genomics, proteomics, and metabolomics, doctors can create personalized treatment plans. One of the commonly used regimens is androgen deprivation therapy (ADT) for advanced prostate cancer. However, as the disease gets worse, many patients stop responding to ADT. Since then, various studies have been done. Scientists have a better understanding of how androgen receptors work. ADT’s role in why cancers become resistant to treatment. A common change seen in prostate cancer is the loss of a gene called PTEN. This gene is linked to cancer progression, making it hard to treat with poor results. Another study is made by investigating the ERCC1 gene. This determines how a tumor responds to radiation or chemotherapy. If this gene is studied, doctors can give personalized plans for cancer treatment with better options.
What Is Precision Medicine?
Precision medicine is a therapy that customizes treatment to every person. The treatment plan is based on their genes, proteins, and environmental factors. It considers both genetic and non-genetic factors when making medical decisions. One of the advantages of personalized medicine is its ability to reduce side effects. Precision medicine also improves patient adherence to treatment and provides economical and personalized care. Precision medicine is not for everyone and comes with a few disadvantages. It includes minimal options or equipment at a few hospitals or clinics, especially to protect patients’ privacy.
Warfarin is an example of how precision medicine works. It is used as a blood thinner; its dosage is adjusted differently for each person based on their genetic makeup. Precision oncology works the same as Warfarin in urological cancers across different populations and age groups.
Importance of Precision Medicine in Urological Cancers:
Do you get a personalized plan for cancer? Yes! Precision medicine aims to provide treatment based on individual needs. Instead of a universal approach, it considers individual factors like genetics. It modifies our ability to anticipate which treatment will be effective and safe for you based on your genes. By planning therapy in this way, precision medicine can reduce expense and time while improving the survival and health of the patient.
How is it possible? Precision medicine allows the diagnosis of cancer at earlier stages, using existing biomarkers and identifying early genetic and epigenetic alterations related to cancer. Interestingly! Precision medicine focuses on prevention and inspires early, proactive action to stop disease progression.
Cancer treatment might sound scary! However, to address this concern, personalized therapy focuses on more effective treatments to avoid side effects, misdiagnosis, and drug toxicity. Developments in personalized medicine cause less dependence on traditional treatments. So, to break it down, if a medication does not work for you, you do not have to try different options until you find the right one. This can lead to various side effects and drug interactions and can even worsen the disease due to delayed treatment, leaving you dissatisfied.
Genetic Factors in Urological Cancers:
In precision medicine, genes are often implicated in cancer's growth and progression. Studies show that cancer cells carry genetic mutations, leading to uncontrolled cell growth and tumor formation. This sounds worrying, doesn't it? But knowing the genetic profile of the tumor and individual makes customizing treatment easier.
A remarkable fact is that testing your genes can help us understand mutations. These mutations are generally involved in cancer growth. So, when these mutational genes are identified, it becomes easier for doctors to predict cancer’s behavior. In turn, it customizes treatment and its efficacy. When the mutations are known, there is a chance of a good treatment outcome with minimal medications and side effects. Sounds great, right? Thank your genes because they avoid long-term treatments and repetitive tests and scans.
Types of Urological Cancers Benefiting from Precision Medicine:
Prostate Cancer:
This type of cancer is diagnosed in men often, with thousands of new incidents every year. The adequacy of treatment plans is decided using different approaches, like TNM staging. It divides prostate cancer into three categories: low, intermediate, and high-risk. Such stratification facilitates the prediction of the probability of survival and the likelihood of the cancer recurring.
Did you know? Basic approaches like TNM classification, Gleason score, or PSA level do not accompany a solution for this magnitude. One critical fact that we note is that 20 to 60 percent of intermediate—and high-risk patients treated with surgery or radiotherapy still have a recurrence of the disease. On the other hand, some low-risk tumors are indolent and are not likely to require high-intensity treatment, which is somewhat comforting.
Because precision cancer treatments attempt to be less invasive, more advanced technologies are essential. Adjusting the treatment pathway to fit the patient’s specific cancer type greatly increases the chances of achieving the desired results. It also reduces the risk of associated complications and provides holistic care and relief.
Bladder Cancer:
Due to its high recurrence rate and expensive treatment, bladder cancer is a health concern. It can be annoying! The two types of bladder cancer are muscle-invasive (MIBC) and non-muscle-invasive (NMIBC). Each has its unique clinical and genetic characteristics. In contrast to MIBC, which is more aggressive and has a higher aptness to spread, NMIBC is frequently associated with mutations in FGFR3 and RAS.
The effectiveness of basic treatments for MIBC, including chemotherapy and major surgery, is limited, particularly for people who are more likely to transmit the disease. However, molecular profiling developments help recognize genetic markers. You might wonder why. These help predict how tumors act and react to treatment.
Also, for precision medicine, COXEN algorithms and gene profiling are known to improve selective therapies. What is the COXEN algorithm? COXEN algorithms are tools installed in a computer to analyze gene patterns. With the help of this tool, a large amount of patient data can be saved. Recording patients' data safely is very helpful in a large hospital setting. Once the data is collected and saved, it can be used to analyze and compare genetic mutations and expressions. This helps determine the suitability of treatment and customization.
Immunotherapy such as PD-1/PD-L-1 (programmed cell death or programmed death ligand) inhibitors have shown promising results in MIBC. All these developments have led to new perceptions of tumor biology and the cellular environment, which can be used in precision medicine for bladder cancer care.
Chronic Kidney Disease (CKD):
CKD is a severe condition influenced by genetic and environmental factors. Single-gene mutations are seen throughout kidney development, and these mutations are discovered with whole-exome and genome sequencing. Various genes influence the occurrence of kidney disease. Treatment is difficult because of gene expression and age-related variations. A quick evolution in molecular genetic testing, followed by next-generation sequencing, has improved the diagnosis of inherited kidney diseases. An exact diagnosis and outlook of CKD can effectively manage the treatment. Thus, precision oncology has given hope to nephrology.
Testicular Cancer:
In young adult men, testicular cancer is common. It makes up about five percent of urological cancers. This sounds stressful. So, to classify testicular cancer and manage it, it is divided into seminomas and non-seminomatous germ cell tumors. They both are unique with different biomarkers. But the exciting thing is that these biomarkers in personalized cancer therapy provide unexpected improvements. According to the studies, several tumor markers help predict the prognosis, which allows the doctor to make well-considered decisions.
Diagnostic Tools in Precision Medicine:
-
Molecular and genetic testing provides a detailed perception of the disease and the person's genetic profile. The tools help the doctor understand the cause and customize the treatment. In precision medicine, the aim is to target the cause directly. With the help of whole-genome sequencing, which studies and analyzes our DNA, and whole-exome sequencing, which examines only the specific DNA parts, treatment is planned to prevent malignancy.
-
A tool called next-generation sequencing quickly reads and analyzes both DNA and RNA. To simplify, it detects mutations, gene expression changes, and other changes related to the disease.
-
Another development in precision medicine is polygenic risk scores (PRS). This uses multiple gene alterations to analyze the risk of disease development among loved ones. Why is PRS important? It allows the planning of preventive and personalized therapies for better outcomes.
-
Protein biomarkers are also used as diagnostic tools in precision medicine. These biomarkers help detect disease, track its course, and respond to treatment.
-
In oncology, non-invasive liquid biopsies detect circulating tumor cells and cell-free DNA. The good news? The doctors do not have to take up painful procedures in liquid biopsies.
-
MicroRNA is also coming as a remedy in cancer research. MicroRNAs are tiny molecules that can influence the spread of cancer and are helpful in the diagnosis and treatment of cancers.
-
Radiomics and imaging using AI technologies help in accurate tumor diagnosis. Aren't these innovations and techniques beyond our imaginations? Not just diagnosis, they provide good results by identifying the exact location of the tumor's origin.
-
Spatial transcriptomics determines the nature and course of disease at the cellular level. It even identifies single-cell mutations, which allows for a clear analysis of single-cell gene expression and its relationship to human cell tissue and disease.
Personalized Treatment Approaches:
So far, we have gotten a little idea about how personalized cancer therapies use unique genetic, molecular, and clinical profiles to find the most effective treatment with fewer side effects. One notable factor in precision medicine is targeted therapy. In this, the drugs are delivered to attack specific cancer-causing gene mutations. Additionally, immunotherapy strengthens the immune function to fight cancer in a better and more natural way.
Not just this, pharmacogenomics guarantees that you get the right drug at the right dose. This is to minimize the side effects and maximize recovery. It does not end here, but even new technologies have become smarter. What does it mean? It means the innovation of gene therapy to target specific, faulty genes involved in certain diseases. Sounds great, right? Also, AI-powered models are helping doctors predict precise drug combinations according to individual needs. These developments are doing wonders in fighting aggressive diseases.
Challenges in Precision Medicine:
It is a known fact that every opportunity comes with great challenges. Precision medicine also comes with challenges, like expensive treatments with limited access. For precision medicine, collecting and preserving patients ' information demands privacy and data security. Sometimes, diagnostic tools can complicate treatment strategies. These include multifactorial genetic and environmental factors, genes, proteins, and molecular biomarkers’ identification, which require specialized tools. Personalized medicine can take time and require clinical trials.
Future of Precision Medicine in Urology:
Precision medicine has changed how we diagnose and treat urological diseases in urology. Examining the genetic and molecular profiles, prostate, bladder, and kidney cancers are classified based on specific genomic changes. One breakthrough is non-invasive biomarkers. These are done using basic urine and blood tests to detect cancer cells. They detect cancer cells, track their course, and prevent invasive procedures. Kudos to technology! It is playing a huge role. AI models help in accurate diagnosis and can predict the treatment response. Additionally, nanotechnology is also in the field. This involves targeted drug administration to attack only the cancer cells, leaving the healthy tissue.
Conclusion:
Combining the latest technologies in precision medicine has been beneficial in early disease detection, personalized treatment plans, and better recovery. Biomarkers like genes, proteins, and molecular profiling allow precise and targeted drug administration. This targeted therapy only attacks the diseased cells and spares the healthy tissue. Though precision medicine comes with some challenges, its benefits outweigh the risks. Continued research will help in the development of precision medicine in oncology.
Key Takeaway/Note from Icliniq
Urological cancers may be treated using precision medicine, which allows a doctor to provide a personalized approach to treatment. Icliniq doctors can help you understand precision medicine. Precision medicine allows the doctor to tailor treatment based on your genetic structure, lifestyle, and other factors. This makes it the most effective approach to targeting specific cancer cells.
